Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR mHealth and uHealth

Date Submitted: Jun 16, 2026
Open Peer Review Period: Jun 17, 2026 - Aug 12, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

A VR-Based Multimodal Intelligent Reading Aid for Low-Vision Adolescents: An Ophthalmic Safety and Functional Evaluation Study

  • Jing Zhong; 
  • Jing Ma; 
  • Shi-Ming Li; 
  • Jin Yuan

ABSTRACT

Background:

Low vision substantially impairs reading ability, educational participation, and access to information among children and adolescents. Existing assistive technologies primarily focus on visual magnification and often provide limited support for higher-level cognitive processing during reading tasks.

Objective:

This study aimed to develop and evaluate a virtual reality (VR)-based multimodal intelligent reading aid integrating image enhancement, optical character recognition (OCR), text-to-speech (TTS), and large language model (LLM)-assisted semantic summarization for low-vision adolescents.

Methods:

This study consisted of 2 sequential components. First, a prospective ophthalmic safety evaluation was conducted in 22 healthy adults to assess the short-term ocular safety and tolerability of the VR device. Ophthalmic examinations included tear film break-up time (TBUT), phoria, accommodative function, intraocular pressure (IOP), best-corrected visual acuity (BCVA), and simulator sickness scores before and after device exposure. Second, a within-subject controlled functional evaluation was conducted in 36 low-vision adolescents aged 9–17 years. Participants completed standardized reading tasks under 2 conditions: unaided reading and VR-assisted reading. Reading completion time was evaluated as the primary outcome. Secondary outcomes included user satisfaction and system usability assessed using the System Usability Scale (SUS). Paired-sample t tests were used for statistical analyses.

Results:

In the ophthalmic safety cohort, no significant changes were observed in TBUT, distance phoria, near phoria, accommodative convergence/accommodation ratio, accommodative response, IOP, BCVA, or simulator sickness scores following VR exposure (all P>.05). No device-related adverse events or clinically significant discomfort were reported. In the functional evaluation cohort, the VR-based reading aid significantly improved reading performance compared with unaided reading. Mean reading completion time decreased from 52.11 (SD 8.83) seconds to 26.53 (SD 3.74) seconds (P<.001), representing an approximately 49% reduction in reading time. User satisfaction was significantly higher under the VR-assisted condition than under the unaided condition (85.56 [SD 4.23] vs 36.53 [SD 11.53]; P<.001). The mean SUS score was 71.32 (SD 3.71), exceeding the established benchmark score of 68 and indicating good overall usability and user acceptance.

Conclusions:

The proposed VR-based multimodal intelligent reading aid demonstrated favorable short-term ocular safety, good usability, and significant improvements in reading efficiency and user satisfaction among low-vision adolescents. By integrating immersive visualization, OCR-based text recognition, auditory feedback, and AI-assisted semantic processing into a unified digital health platform, the system may represent a promising approach for enhancing reading accessibility, educational participation, and independent learning in visually impaired populations. Clinical Trial: ClinicalTrials.gov 2024LSPJ164


 Citation

Please cite as:

Zhong J, Ma J, Li SM, Yuan J

A VR-Based Multimodal Intelligent Reading Aid for Low-Vision Adolescents: An Ophthalmic Safety and Functional Evaluation Study

JMIR Preprints. 16/06/2026:104703

DOI: 10.2196/preprints.104703

URL: https://preprints.jmir.org/preprint/104703

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.